Summary of Drugs You Don't Need for Disorders You Don't Have

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

Drugs You Don't Need for Disorders You Don't Have summary
Start getting smarter:
or see our plans




  • Innovative


Do drug advertisements really help American consumers? Do they make people more aware of newer, better treatment options? Or are these ads just keeping pharmaceutical companies profitable as true innovation diminishes? Senior national correspondent for The Huffington Post, Jonathan Cohn, successfully addresses these questions through expert analysis of the effect of drug ads upon consumer behaviors and exploration of possible remedies to misleading drug marketing practices. getAbstract recommends Cohn’s findings to everyone interested in consumer advocacy and health care trends.

About the Author

Jonathan Cohn is a senior national correspondent for The Huffington Post. He is also the author of Sick: The Untold Story of America’s Health Care Crisis – and the People Who Pay the Price.



The United States is one of the only nations in the world that allows drug manufactures to market prescription medications directly to consumers. Prior to the 1980s, drug sales pitches focused on physicians. Then, in 1981, Merck ran its first consumer-directed ad in the Reader’s Digest; other pharmaceutical companies soon followed suit. Some argue that drug ads benefit the public by increasing awareness about diseases and treatment options. However, antidrug ad advocates raise a number of concerns.

Over the years, drug advertisements...

More on this topic

Customers who read this summary also read

Cancer Pill Costs Soar as Drug Companies Retain Pricing Power
How VR Could Break America’s Opioid Addiction
The Lawyer Who Beat Big Tobacco Takes on the Opioid Industry
Will Quantum Computing Transform Biopharma R&D?
America's Most Admired Lawbreaker

Related Channels

Comment on this summary